A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder

Yanquan LIU; Xiaomei HU; Yue YIN; Lin LIN; Jianzhen SHEN; Yuting CHEN; Huanwen TANG

doi:10.19401/j.cnki.1007-3639.2022.07.009

您当前的位置：

首页 >

文章列表页 >

A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder

Case Report | 更新时间：2025-12-31

- A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
- China Oncology Vol. 32, Issue 7, Pages: 650-656(2022)
- 作者机构：
  
  1. 广东医科大学研究生院第一临床医学院血液内科,广东东莞 523808
  2. 广东省东莞市环境医学重点实验室,广东东莞 523808
  3. 福建医科大学附属协和医院病理科,福建福州 350001
  4. 福建医科大学附属协和医院血液病研究所,福建福州 350001
  5. 福建医科大学附属协和医院影像科,福建福州 350001
- 作者简介：
  
  TANG Huanwen, E-mail: thw@gdmu.edu.cn.
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.07.009
  CLC： R733.4
- Received：26 March 2022，
  
  Published：30 July 2022
- 稿件说明：
移动端阅览
Yanquan LIU, Xiaomei HU, Yue YIN, et al. A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder[J]. China Oncology, 2022, 32(7): 650-656.
DOI：

Yanquan LIU, Xiaomei HU, Yue YIN, et al. A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder[J]. China Oncology, 2022, 32(7): 650-656. DOI： 10.19401/j.cnki.1007-3639.2022.07.009.

摘要

Abstract

关键词

Keywords

references

LAU E , MOYERS J T , WANG B C , et al . Analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with Epstein-Barr virus (EBV) assessments-a single tertiary referral center experience and review of literature [J ] . Cancers (Basel) , 2021 , 13 ( 4 ): 899.

SWERDLOW S H , CAMPO E , PILERI S A , et al . The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J ] . Blood , 2016 , 127 ( 20 ): 2375 - 2390 . DOI: 10.1182/blood-2016-01-643569 http://doi.org/10.1182/blood-2016-01-643569 https://ashpublications.org/blood/article/127/20/2375/35286/The-2016-revision-of-the-World-Health-Organization https://ashpublications.org/blood/article/127/20/2375/35286/The-2016-revision-of-the-World-Health-Organization

STYCZYNSKI J , VAN DER VELDEN W , FOX C P , et al . Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European Conference on Infections in Leukemia (ECIL-6) guidelines [J ] . Haematologica , 2016 , 101 ( 7 ): 803 - 811 . DOI: 10.3324/haematol.2016.144428 http://doi.org/10.3324/haematol.2016.144428 http://www.haematologica.org/cgi/doi/10.3324/haematol.2016.144428 http://www.haematologica.org/cgi/doi/10.3324/haematol.2016.144428

SCHIEFER A I , SALZER E , FÜREDER A , et al . PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: an inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories [J ] . Cancer Med , 2019 , 8 ( 10 ): 4656 - 4668 . DOI: 10.1002/cam4.2394 http://doi.org/10.1002/cam4.2394 https://onlinelibrary.wiley.com/doi/10.1002/cam4.2394 https://onlinelibrary.wiley.com/doi/10.1002/cam4.2394

PETRARA M R , GIUNCO S , SERRAINO D , et al . Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment [J ] . Cancer Lett , 2015 , 369 ( 1 ): 37 - 44 . DOI: 10.1016/j.canlet.2015.08.007 http://doi.org/10.1016/j.canlet.2015.08.007 https://linkinghub.elsevier.com/retrieve/pii/S0304383515005364 https://linkinghub.elsevier.com/retrieve/pii/S0304383515005364

OPELZ G , HENDERSON R . Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients [J ] . Lancet , 1993 , 342 ( 8886/8887 ): 1514 - 1516 . DOI: 10.1016/S0140-6736(05)80084-4 http://doi.org/10.1016/S0140-6736(05)80084-4 https://linkinghub.elsevier.com/retrieve/pii/S0140673605800844 https://linkinghub.elsevier.com/retrieve/pii/S0140673605800844

COCKFIELD S M . Identifying the patient at risk for post-transplant lymphoproliferative disorder [J ] . Transpl Infect Dis , 2001 , 3 ( 2 ): 70 - 78 . DOI: 10.1034/j.1399-3062.2001.003002070.x http://doi.org/10.1034/j.1399-3062.2001.003002070.x http://doi.wiley.com/10.1034/j.1399-3062.2001.003002070.x http://doi.wiley.com/10.1034/j.1399-3062.2001.003002070.x

OPELZ G , DÖHLER B . Lymphomas after solid organ transplantation: a collaborative transplant study report [J ] . Am J Transplant , 2004 , 4 ( 2 ): 222 - 230 . DOI: 10.1046/j.1600-6143.2003.00325.x http://doi.org/10.1046/j.1600-6143.2003.00325.x http://doi.wiley.com/10.1046/j.1600-6143.2003.00325.x http://doi.wiley.com/10.1046/j.1600-6143.2003.00325.x

WISTINGHAUSEN B , GROSS T G , BOLLARD C . Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients [J ] . Pediatr Hematol Oncol , 2013 , 30 ( 6 ): 520 - 531 . DOI: 10.3109/08880018.2013.798844 http://doi.org/10.3109/08880018.2013.798844 https://www.tandfonline.com/doi/full/10.3109/08880018.2013.798844 https://www.tandfonline.com/doi/full/10.3109/08880018.2013.798844

UHLIN M , WIKELL H , SUNDIN M , et al . Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation [J ] . Haematologica , 2014 , 99 ( 2 ): 346 - 352 . DOI: 10.3324/haematol.2013.087338 http://doi.org/10.3324/haematol.2013.087338 http://www.haematologica.org/cgi/doi/10.3324/haematol.2013.087338 http://www.haematologica.org/cgi/doi/10.3324/haematol.2013.087338

NAKANISHI C , KAWAGISHI N , SEKIGUCHI S , et al . Post-transplantation lymphoproliferative disorder in living-donor liver transplantation: a single-center experience [J ] . Surg Today , 2012 , 42 ( 8 ): 741 - 751 . DOI: 10.1007/s00595-012-0127-7 http://doi.org/10.1007/s00595-012-0127-7 http://link.springer.com/10.1007/s00595-012-0127-7 http://link.springer.com/10.1007/s00595-012-0127-7

STYCZYNSKI J , GIL L , TRIDELLO G , et al . Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the European group for blood and marrow transplantation [J ] . Clin Infect Dis , 2013 , 57 ( 6 ): 794 - 802 . DOI: 10.1093/cid/cit391 http://doi.org/10.1093/cid/cit391 https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cit391 https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cit391

DIERICKX D , HABERMANN T M . Post-transplantation lymphoproliferative disorders in adults [J ] . N Engl J Med , 2018 , 378 ( 6 ): 549 - 562 . DOI: 10.1056/NEJMra1702693 http://doi.org/10.1056/NEJMra1702693 http://www.nejm.org/doi/10.1056/NEJMra1702693 http://www.nejm.org/doi/10.1056/NEJMra1702693

LUSKIN M R , HEIL D S , TAN K S , et al . The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder [J ] . Am J Transplant , 2015 , 15 ( 10 ): 2665 - 2673 . DOI: 10.1111/ajt.13324 http://doi.org/10.1111/ajt.13324 https://onlinelibrary.wiley.com/doi/10.1111/ajt.13324 https://onlinelibrary.wiley.com/doi/10.1111/ajt.13324

DESTEFANO C B , DESAI S H , SHENOY A G , et al . Management of post-transplant lymphoproliferative disorders [J ] . Br J Haematol , 2018 , 182 ( 3 ): 330 - 343 . DOI: 10.1111/bjh.15263 http://doi.org/10.1111/bjh.15263 https://onlinelibrary.wiley.com/doi/10.1111/bjh.15263 https://onlinelibrary.wiley.com/doi/10.1111/bjh.15263

MALONEY E M , BUSQUE V A , HUI S T , et al . Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder [J ] . JCI Insight , 2020 , 5 ( 6 ): 131644.

GULLEY M L , TANG W H . Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder [J ] . Clin Microbiol Rev , 2010 , 23 ( 2 ): 350 - 366 . DOI: 10.1128/CMR.00006-09 http://doi.org/10.1128/CMR.00006-09 https://journals.asm.org/doi/10.1128/CMR.00006-09 https://journals.asm.org/doi/10.1128/CMR.00006-09

中华医学会器官移植学分会 . 器官移植受者EB病毒感染和移植后淋巴组织增生性疾病临床诊疗规范(2019版) [J ] . 器官移植 , 2019 , 10 ( 2 ): 149 - 157 .

Branch of Organ Transplantation of Chinese Medical Association . Diagnosis and treatment specification for EB virus infection and posttransplant lymphoproliferative disease on recipients with organ transplantation in China (2019 edition) [J ] . Organ Transplant , 2019 , 10 ( 2 ): 149 - 157 .

KANAKRY J A , HEGDE A M , DURAND C M , et al . The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases [J ] . Blood , 2016 , 127 ( 16 ): 2007 - 2017 . DOI: 10.1182/blood-2015-09-672030 http://doi.org/10.1182/blood-2015-09-672030 https://ashpublications.org/blood/article/127/16/2007/34862/The-clinical-significance-of-EBV-DNA-in-the-plasma https://ashpublications.org/blood/article/127/16/2007/34862/The-clinical-significance-of-EBV-DNA-in-the-plasma

KIMURA H , KWONG Y L . EBV viral loads in diagnosis, monitoring, and response assessment [J ] . Front Oncol , 2019 , 9 : 62 . DOI: 10.3389/fonc.2019.00062 http://doi.org/10.3389/fonc.2019.00062 https://www.frontiersin.org/article/10.3389/fonc.2019.00062/full https://www.frontiersin.org/article/10.3389/fonc.2019.00062/full

ALLEN U D , PREIKSAITIS J K , AST INFECTIOUS DISEASES COMMUNITY OF PRACTICE . Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation [J ] . Am J Transplant , 2013 , 13 ( Suppl 4 ): 107 - 120 . DOI: 10.1111/ajt.12104 http://doi.org/10.1111/ajt.12104 https://onlinelibrary.wiley.com/doi/10.1111/ajt.12104 https://onlinelibrary.wiley.com/doi/10.1111/ajt.12104

CAMPO E , SWERDLOW S H , HARRIS N L , et al . The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J ] . Blood , 2011 , 117 ( 19 ): 5019 - 5032 . DOI: 10.1182/blood-2011-01-293050 http://doi.org/10.1182/blood-2011-01-293050 https://ashpublications.org/blood/article/117/19/5019/20991/The-2008-WHO-classification-of-lymphoid-neoplasms https://ashpublications.org/blood/article/117/19/5019/20991/The-2008-WHO-classification-of-lymphoid-neoplasms

RAUSCH L , KOENECKE C , KOCH H F , et al . Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation [J ] . Transplant Res , 2016 , 5 : 6 . DOI: 10.1186/s13737-016-0036-1 http://doi.org/10.1186/s13737-016-0036-1 http://transplantationresearch.biomedcentral.com/articles/10.1186/s13737-016-0036-1 http://transplantationresearch.biomedcentral.com/articles/10.1186/s13737-016-0036-1

刘彦权 , 沈建箴 , 刘庭波 , 等 . 第504例孕32周、贫血—顽固性溶血性贫血—重症肺部感染—心功能不全—左肾占位—弥漫大B细胞淋巴瘤 [J ] . 中华医学杂志 , 2020 , 100 ( 20 ): 1588 - 1592 .

LIU Y Q , SHEN J Z , LIU T B , et al . Case 504, 32 weeks of gestation, anemia-refractory hemolytic anemia-severe pulmonary infection-cardiac dysfunction-left renal mass-diffuse large B-cell lymphoma [J ] . Natl Med J China , 2020 , 100 ( 20 ): 1588 - 1592 .

READY E , CHERNUSHKIN K , PARTOVI N , et al . Posttransplant lymphoproliferative disorder in adults receiving kidney transplantation in British Columbia: a retrospective cohort analysis [J ] . Can J Kidney Health Dis , 2018 , 5 : 2054358118760831.

TAOKA K , NANNYA Y , YAMAMOTO G , et al . Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer [J ] . Am J Hematol , 2009 , 84 ( 9 ): 600 - 603 . DOI: 10.1002/ajh.21479 http://doi.org/10.1002/ajh.21479 https://onlinelibrary.wiley.com/doi/10.1002/ajh.21479 https://onlinelibrary.wiley.com/doi/10.1002/ajh.21479

AFSHAR K , RAO A P , PATEL V , et al . Use of foscarnet therapy for EBV infection following control of PTLD with enhancement of cellular immunity in a lung-transplant recipient [J ] . J Transplant , 2011 , 2011 : 919651.

HÖCKER B , BÖHM S , FICKENSCHER H , et al . (Val-) Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation [J ] . Transpl Int , 2012 , 25 ( 7 ): 723 - 731 . DOI: 10.1111/j.1432-2277.2012.01485.x http://doi.org/10.1111/j.1432-2277.2012.01485.x https://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2012.01485.x https://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2012.01485.x

PETERS A C , AKINWUMI M S , CERVERA C , et al . The changing epidemiology of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients over 30 years: a single-center experience [J ] . Transplantation , 2018 , 102 ( 9 ): 1553 - 1562 . DOI: 10.1097/TP.0000000000002146 http://doi.org/10.1097/TP.0000000000002146 https://journals.lww.com/00007890-201809000-00031 https://journals.lww.com/00007890-201809000-00031

PARKER A , BOWLES K , BRADLEY J A , et al . Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients-BCSH and BTS guidelines [J ] . Br J Haematol , 2010 , 149 ( 5 ): 693 - 705 . DOI: 10.1111/j.1365-2141.2010.08160.x http://doi.org/10.1111/j.1365-2141.2010.08160.x https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08160.x https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08160.x

TSAI D E , HARDY C L , TOMASZEWSKI J E , et al . Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients [J ] . Transplantation , 2001 , 71 ( 8 ): 1076 - 1088 . DOI: 10.1097/00007890-200104270-00012 http://doi.org/10.1097/00007890-200104270-00012 http://journals.lww.com/00007890-200104270-00012 http://journals.lww.com/00007890-200104270-00012

GHOBRIAL I M , HABERMANN T M , RISTOW K M , et al . Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era [J ] . Leuk Lymphoma , 2005 , 46 ( 2 ): 191 - 196 . DOI: 10.1080/10428190400012011 http://doi.org/10.1080/10428190400012011 https://www.tandfonline.com/doi/full/10.1080/10428190400012011 https://www.tandfonline.com/doi/full/10.1080/10428190400012011

CHOQUET S , LEBLOND V , HERBRECHT R , et al . Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study [J ] . Blood , 2006 , 107 ( 8 ): 3053 - 3057 . DOI: 10.1182/blood-2005-01-0377 http://doi.org/10.1182/blood-2005-01-0377 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-01-0377 http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-01-0377

BISHNOI R , BAJWA R , FRANKE A J , et al . Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients [J ] . Exp Hematol Oncol , 2017 , 6 : 26 . DOI: 10.1186/s40164-017-0087-0 http://doi.org/10.1186/s40164-017-0087-0 https://doi.org/10.1186/s40164-017-0087-0 https://doi.org/10.1186/s40164-017-0087-0

TRAPPE R U , DIERICKX D , ZIMMERMANN H , et al . Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase Ⅱ trial [J ] . J Clin Oncol , 2017 , 35 ( 5 ): 536 - 543 .

TRAPPE R , OERTEL S , LEBLOND V , et al . Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial [J ] . Lancet Oncol , 2012 , 13 ( 2 ): 196 - 206 . DOI: 10.1016/S1470-2045(11)70300-X http://doi.org/10.1016/S1470-2045(11)70300-X https://linkinghub.elsevier.com/retrieve/pii/S147020451170300X https://linkinghub.elsevier.com/retrieve/pii/S147020451170300X

MYNAREK M , SCHOBER T , BEHRENDS U , et al . Posttransplant lymphoproliferative disease after pediatric solid organ transplantation [J ] . Clin Dev Immunol , 2013 , 2013 : 814973.

GROSS T G , ORJUELA M A , PERKINS S L , et al . Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a children’s oncology group report [J ] . Am J Transplant , 2012 , 12 ( 11 ): 3069 - 3075 . DOI: 10.1111/j.1600-6143.2012.04206.x http://doi.org/10.1111/j.1600-6143.2012.04206.x https://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2012.04206.x https://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2012.04206.x

Views

1315

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinicopathologic analysis of benign and malignant ovarian goiter

Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis

Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study

Impact of radiation-induced lymphopenia on prognosis in patients with limited-stage small cell lung cancer: a cohort study

MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Related Author

卿松

李晓红

苗娜

刘霞

马遇庆

张巍

CHANG Kesheng

SHAO Jin

Related Institution

新疆医科大学第一附属医院病理科

新疆医科大学第一附属医院妇科

Department of Pathology, Wuxi Second People’s Hospital

Department of Pathology, Affiliated Hospital of Nantong University

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors

AI问答

⁰